Article
Hepatitis B exacerbation with a precore mutant virus following withdrawal of lamivudine in a human immunodeficiency virus-infected patient.
The Journal of infection - 1 Sept 2000
Neau D, Schvoerer E, Robert D, Dubois F, Dutronc H, Fleury H J, Ragnaud J M
Abstract excerpt
Chronic active hepatitis B exacerbations have been reported following development of resistance to or withdrawal of lamivudine in HIV-infected patients. A 38-year-old woman with HIV and chronic HBV infections was hospitalized because of acute hepatitis. The occurrence of cytolysis with replication of HBV 2 months after withdrawing lamivudine suggests that our patient experienced a severe reactivation of HBV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
